Finanza

Global Blood Therapeutics, Inc.: giudizio positivo di Guggenheim

This content has been archived. It may no longer be relevant

Global Blood Therapeutics, Inc.: giudizio positivo di Guggenheim

Global Blood Therapeutics


FIMA2681# 2022-08-08T22:01:03+02:00

Show More